Company: LENZ
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001815776-25-000071
Chunk: 271

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part II, Item 2
Chunk 271
---
 requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LENZ THERAPEUTICS, INC.Dated: November 5, 2025By:/s/ Evert SchimmelpenninkName:Evert SchimmelpenninkTitle:Chief Executive Officer(Principal Executive Officer)Dated: November 5, 2025By:/s/ Daniel ChevallardName:Daniel ChevallardTitle:Chief Financial Officer(Principal Financial and Accounting Officer)

82